Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
vYF vs Licensed YF Vaccines in Pediatric Population
NCT07103148Phase 3Recruiting
- Sponsor
- Sanofi
- Start
- Jul 2025
- Primary completion
- Nov 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of SP0218 in yellow fever, sponsored by Sanofi. Started Jul 2025; status: recruiting.
02
Drugs
SP0218
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT07103148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07103148.